uniQure (QURE) Profit After Tax (2016 - 2026)
uniQure (QURE) posted quarterly Profit After Tax of -$81.1 million for Q2 2026, down 89.31% year-over-year from -$758.6 million in Q2 2025, and down 46.85% quarter-over-quarter from -$55.2 million in Q1 2026.
uniQure (QURE) Profit After Tax (2016 - 2026) Analysis & Trends
uniQure's Profit After Tax history runs 11 years deep, the most recent figure standing at -$81.1 million for Q2 2026.
- In Q2 2026, Profit After Tax fell 89.31% year-over-year to -$81.1 million; the TTM figure through Jun 2026 stood at -$253.3 million (down 25.22% YoY), while the FY2025 annual figure was -$204.4 million, up 14.68% from the prior year.
- Profit After Tax for Q2 2026 stood at -$81.1 million, down from -$55.2 million in the prior quarter.
- The five-year high for Profit After Tax was $41.5 million in Q4 2022, with the low at -$95.7 million in Q3 2023.
- The 5-year median for Profit After Tax is -$67.7 million (2022), against an average of -$58.1 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax surged 1601.48% in 2022, then plunged 275.69% in 2023.
- uniQure's Profit After Tax stood at $41.5 million in 2022, then slumped by 275.69% to -$72.9 million in 2023, then rose by 3.87% to -$70.1 million in 2024, then soared by 47.85% to -$36.6 million in 2025, then tumbled by 121.7% to -$81.1 million in 2026.
- Business Quant data shows QURE's Profit After Tax at -$81.1 million in Q2 2026, -$55.2 million in Q1 2026, and -$36.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | -81.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -81.06 Mn |
| Mar 31, 2026 | -55.20 Mn |
| Dec 31, 2025 | -36.56 Mn |
| Sep 30, 2025 | -80.53 Mn |
| Jun 30, 2025 | -42.82 Mn |
| Mar 31, 2025 | -44.64 Mn |
| Dec 31, 2024 | -70.12 Mn |
| Sep 30, 2024 | -44.76 Mn |
| Jun 30, 2024 | -56.58 Mn |
| Mar 31, 2024 | -68.11 Mn |
| Dec 31, 2023 | -72.94 Mn |
| Sep 30, 2023 | -95.69 Mn |
| Jun 30, 2023 | -68.42 Mn |
| Mar 31, 2023 | -71.43 Mn |
| Dec 31, 2022 | 41.52 Mn |
| Sep 30, 2022 | -73.23 Mn |
| Jun 30, 2022 | -67.39 Mn |
| Mar 31, 2022 | -57.13 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | -49.82 Mn |